-
Something wrong with this record ?
Half-Sandwich Ru(II) and Os(II) Bathophenanthroline Complexes Containing a Releasable Dichloroacetato Ligand
P. Štarha, Z. Trávníček, J. Vančo, Z. Dvořák,
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 1997
Free Medical Journals
from 1997
PubMed Central
from 2001
Europe PubMed Central
from 2001
ProQuest Central
from 1997-01-01
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 2009-03-01
Health & Medicine (ProQuest)
from 1997-01-01
- MeSH
- Phenanthrolines chemistry pharmacology MeSH
- Coordination Complexes chemistry pharmacology MeSH
- Dichloroacetic Acid chemistry pharmacology MeSH
- Humans MeSH
- Ligands MeSH
- Ovarian Neoplasms drug therapy MeSH
- Osmium chemistry MeSH
- Cell Proliferation drug effects MeSH
- Ruthenium chemistry MeSH
- Drug Liberation MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
We report on the preparation and thorough characterization of cytotoxic half-sandwich complexes [Ru(η⁶-pcym)(bphen)(dca)]PF₆ (Ru-dca) and [Os(η⁶-pcym)(bphen)(dca)]PF₆ (Os-dca) containing dichloroacetate(1-) (dca) as the releasable O-donor ligand bearing its own cytotoxicity; pcym = 1-methyl-4-(propan-2-yl)benzene (p-cymene), bphen = 4,7-diphenyl-1,10-phenanthroline (bathophenanthroline). Complexes Ru-dca and Os-dca hydrolyzed in the water-containing media, which led to the dca ligand release (supported by ¹H NMR and electrospray ionization mass spectra). Mass spectrometry studies revealed that complexes Ru-dca and Os-dca do not interact covalently with the model proteins cytochrome c and lysozyme. Both complexes exhibited slightly higher in vitro cytotoxicity (IC50 = 3.5 μM for Ru-dca, and 2.6 μM for Os-dca) against the A2780 human ovarian carcinoma cells than cisplatin (IC50 = 5.9 μM), while their toxicity on the healthy human hepatocytes was found to be IC50 = 19.1 μM for Ru-dca and IC50 = 19.7 μM for Os-dca. Despite comparable cytotoxicity of complexes Ru-dca and Os-dca, both the complexes modified the cell cycle, mitochondrial membrane potential, and mitochondrial cytochrome c release by a different way, as revealed by flow cytometry experiments. The obtained results point out the different mechanisms of action between the complexes.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033317
- 003
- CZ-PrNML
- 005
- 20181010124957.0
- 007
- ta
- 008
- 181008s2018 sz f 000 00|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules23020420 $2 doi
- 035 __
- $a (PubMed)29443934
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Štarha, Pavel $u Department of Inorganic Chemistry & Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University in Olomouc, 17. listopadu 12, 771 46 Olomouc, Czech Republic. pavel.starha@upol.cz.
- 245 10
- $a Half-Sandwich Ru(II) and Os(II) Bathophenanthroline Complexes Containing a Releasable Dichloroacetato Ligand / $c P. Štarha, Z. Trávníček, J. Vančo, Z. Dvořák,
- 520 9_
- $a We report on the preparation and thorough characterization of cytotoxic half-sandwich complexes [Ru(η⁶-pcym)(bphen)(dca)]PF₆ (Ru-dca) and [Os(η⁶-pcym)(bphen)(dca)]PF₆ (Os-dca) containing dichloroacetate(1-) (dca) as the releasable O-donor ligand bearing its own cytotoxicity; pcym = 1-methyl-4-(propan-2-yl)benzene (p-cymene), bphen = 4,7-diphenyl-1,10-phenanthroline (bathophenanthroline). Complexes Ru-dca and Os-dca hydrolyzed in the water-containing media, which led to the dca ligand release (supported by ¹H NMR and electrospray ionization mass spectra). Mass spectrometry studies revealed that complexes Ru-dca and Os-dca do not interact covalently with the model proteins cytochrome c and lysozyme. Both complexes exhibited slightly higher in vitro cytotoxicity (IC50 = 3.5 μM for Ru-dca, and 2.6 μM for Os-dca) against the A2780 human ovarian carcinoma cells than cisplatin (IC50 = 5.9 μM), while their toxicity on the healthy human hepatocytes was found to be IC50 = 19.1 μM for Ru-dca and IC50 = 19.7 μM for Os-dca. Despite comparable cytotoxicity of complexes Ru-dca and Os-dca, both the complexes modified the cell cycle, mitochondrial membrane potential, and mitochondrial cytochrome c release by a different way, as revealed by flow cytometry experiments. The obtained results point out the different mechanisms of action between the complexes.
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a komplexní sloučeniny $x chemie $x farmakologie $7 D056831
- 650 _2
- $a kyselina dichloroctová $x chemie $x farmakologie $7 D003999
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a osmium $x chemie $7 D009992
- 650 _2
- $a nádory vaječníků $x farmakoterapie $7 D010051
- 650 _2
- $a fenantroliny $x chemie $x farmakologie $7 D010618
- 650 _2
- $a ruthenium $x chemie $7 D012428
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Trávníček, Zdeněk $u Department of Inorganic Chemistry & Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University in Olomouc, 17. listopadu 12, 771 46 Olomouc, Czech Republic. zdenek.travnicek@upol.cz.
- 700 1_
- $a Vančo, Ján $u Department of Inorganic Chemistry & Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University in Olomouc, 17. listopadu 12, 771 46 Olomouc, Czech Republic. jan.vanco@upol.cz.
- 700 1_
- $a Dvořák, Zdeněk $u Department of Cell Biology and Genetics & Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University in Olomouc, Šlechtitelů 27, 783 71 Olomouc, Czech Republic. zdenek.dvorak@upol.cz.
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 23, č. 2 (2018)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29443934 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181010125447 $b ABA008
- 999 __
- $a ok $b bmc $g 1340878 $s 1030311
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 23 $c 2 $e 20180214 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20181008